Acumen Pharmaceuticals, Inc. (ABOS) - Quarterly Income Statement

Home
ABOS
Financials

0.9801 (USD) • At close May 9, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	0.29	0	0	0	0	0	0	0	0	0	0	0	1.436	0.73	0.151	0.226
Cost of Revenue Numbers are in millions	0	0	0.045	0.044	0.039	0.04	0.053	0.052	0.049	0.044	0.039	0.037	0.003	0.001	2.254	2.531	1.026	2.994	1.927	2.05
Gross Profit Numbers are in millions	0	0	-0.045	-0.044	0.251	-0.04	-0.053	-0.052	-0.049	-0.044	-0.039	-0.037	-0.003	-0.001	-2.254	-2.531	0.41	-2.264	-1.776	-1.824
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.866	0	0	0	0	0	0	0	0	0	0	0	0.286	-3.101	-11.762	-8.071
Reseach & Development Expenses Numbers are in millions	34.569	27.247	19.533	12.449	13.293	11.179	9.133	8.713	10.746	8.309	7.321	5.985	5.673	1.8	2.254	2.578	1.026	2.994	1.927	2.05
General & Administrative Expenses Numbers are in millions	5.028	5.018	4.848	5.325	5.193	4.86	4.345	4.422	3.502	3.062	3.09	3.221	2.742	2.135	1.187	1.215	0.644	0.226	0.259	0.222
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-0.039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.028	5.018	4.848	5.325	5.154	4.86	4.345	4.422	3.502	3.062	3.09	3.221	2.742	2.135	1.187	1.215	0.644	0.226	0.259	0.222
Other Expenses Numbers are in millions	0	0	0	-0.054	-0.021	-0.042	-0.016	-0.004	-0.01	-0.002	0	0.001	0.004	0.019	0.019	0.009	1.107	0	0	0
Operating Expenses Numbers are in millions	39.597	32.265	24.381	17.774	18.447	16.039	13.478	13.135	14.248	11.371	10.411	9.206	8.415	3.935	3.441	3.793	2.777	2.49	2.186	2.272
Operating Income Numbers are in millions	-39.597	-32.265	-24.381	-17.774	-18.486	-16.039	-13.478	-13.135	-14.248	-11.371	-10.411	-9.206	-8.415	-3.935	-3.441	-3.793	-1.341	-2.49	-2.035	-2.046
Operating Income Ratio Numbers are in millions	0	0	0	0	-63.745	0	0	0	0	0	0	0	0	0	0	0	-0.934	-3.411	-13.477	-9.053
Total Other Income Expenses Net Numbers are in millions	2.443	2.5	3.844	2.901	1.989	3.082	1.868	1.828	1.382	0.661	0.26	0.077	0.066	0.033	-57.917	-23.204	0.586	0	0	0.001
Income Before Tax Numbers are in millions	-37.154	-29.765	-20.537	-14.873	-16.497	-12.957	-11.61	-11.307	-12.866	-10.71	-10.151	-9.129	-8.349	-3.902	-61.358	-26.997	-0.755	-2.49	-2.035	-2.045
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-56.886	0	0	0	0	0	0	0	0	0	0	0	-0.526	-3.411	-13.477	-9.049
Income Tax Expense Numbers are in millions	0	0	0	-0.044	3.752	-0.04	-1.884	-1.828	0.998	-0.661	-0.26	-0.077	-0.066	-0.056	57.917	23.204	-0.586	-2.49	-2.035	-0.001
Net Income Numbers are in millions	-37.154	-29.765	-20.537	-14.873	-16.497	-12.957	-11.61	-9.479	-13.864	-10.049	-9.891	-9.052	-8.349	-3.902	-61.358	-26.997	-0.755	-2.49	-2.035	-2.045
Net Income Ratio Numbers are in millions	0	0	0	0	-56.886	0	0	0	0	0	0	0	0	0	0	0	-0.526	-3.411	-13.477	-9.049
EPS Numbers are in millions	-0.62	-0.5	-0.34	-0.25	-0.28	-0.24	-0.28	-0.23	-0.34	-0.25	-0.24	-0.22	-0.22	-0.1	-1.59	-0.73	-0.026	-0.087	-0.071	-0.071
EPS Diluted Numbers are in millions	-0.62	-0.5	-0.34	-0.25	-0.28	-0.24	-0.28	-0.23	-0.34	-0.25	-0.24	-0.22	-0.22	-0.1	-1.59	-0.73	-0.026	-0.087	-0.071	-0.071
EBITDA Numbers are in millions	-36.073	-28.693	-19.488	-13.829	-13.471	-16.039	-11.557	-11.255	-14.236	-11.371	-10.411	-9.169	-8.369	-3.935	-3.441	-3.793	-1.342	-2.49	-2.035	0.001
EBITDA Ratio Numbers are in millions	0	0	0	0	-46.452	0	0	0	0	0	0	0	0	0	0	0	-0.935	-3.411	-13.477	0.004

Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS Add to watchlist

NASDAQ:ABOS